27 min listen
ASH VTE Guidelines & COVID-19 Update: Use of Anticoagulation in Patients With COVID-19, With Drs. Laura Michaelis, Adam Cuker & Reem Mustafa
FromThe Hematologist
ASH VTE Guidelines & COVID-19 Update: Use of Anticoagulation in Patients With COVID-19, With Drs. Laura Michaelis, Adam Cuker & Reem Mustafa
FromThe Hematologist
ratings:
Length:
18 minutes
Released:
Oct 1, 2021
Format:
Podcast episode
Description
In this installment of our ASH Clinical Practice Guidelines and our COVID-19 series, Editor-in-Chief Dr. Laura Michaelis has a conversation with the Use of Anticoagulation in Patients with COVID-19 guideline panel co-chairs Dr. Adam Cuker and Dr. Reem Mustafa. They discuss the clinical importance of these guidelines as well as the process to track and respond to the ongoing emergence of new clinical data and evidence. For more information on these guidelines, and how you can get involved, visit www.hematology.org/VTEguidelines and for additional constantly-updated COVID-19 resources, visit www.hematology.org/covid-19. While we regularly review and update the links, resources, and FAQs posted on the ASH website to reflect the best information available at a given point in time, the COVID-19 pandemic is a rapidly evolving global health crisis. Please take note of the dates of publication for each podcast.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Oct 1, 2021
Format:
Podcast episode
Titles in the series (100)
BCL-2 Is an Effective Target in Chronic Lymphocytic Leukemia: In her Diffusion article from the May/June issue of The Hematologist, Dr. Ann LaCasce (Dana-Farber Cancer Institute) discusses the use of the recently FDA-approved drug venetoclax for the treatment of patients with chronic lymphocytic leukemia (CLL) or sm by The Hematologist